are approved for venous thromboembolism (VTE) prophylaxis. Which agent is superior remains controversial. OBJECTIVE: To compare the effectiveness, complications, and costs of UFH and LMWH as VTE ...
Background: Venous thromboembolism (VTE) disease prophylaxis rates among medical inpatients have been noted to be <50%. Objective: Our objective was to evaluate the effectiveness and safety of a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results